Concord Wealth Partners Invitae Corp Transaction History

Concord Wealth Partners

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Apr 30, 2024	BUY	$0.6 - $1.53 $82 - $209	137 New	137 $0
Q1 2023 Apr 26, 2023	SELL	$1.2 - $2.73 $19 - $43	-16 Reduced 10.46%	137 $0
Q4 2022 Jan 27, 2023	BUY	$1.71 - $3.61 $261 - $552	153 New	153 $0
Q2 2022 Aug 04, 2022	SELL	$2.13 - $9.01 $869 - $3,676	-408 Reduced 18.92%	1,749 $4,000
Q1 2022 Apr 20, 2022	SELL	$6.28 - $15.59 $3,585 - $8,901	-571 Reduced 20.93%	2,157 $17,000
Q4 2021 Jan 21, 2022	BUY	$14.7 - $28.67 $25,739 - $50,201	1,751 Added 179.22%	2,728 $42,000
Q3 2021 Nov 09, 2021	SELL	$24.31 - $33.6 $35,249 - $48,720	-1,450 Reduced 59.74%	977 $28,000
Q2 2021 Jul 29, 2021	SELL	$26.09 - $40.4 $25,724 - $39,834	-986 Reduced 28.89%	2,427 $82,000
Q1 2021 May 13, 2021	BUY	$33.06 - $56.93 $108,007 - $185,990	3,267 Added 2237.67%	3,413 $130,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $5,707 - $8,380	146 New	146 $6,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.